FDA Drug recall D-0315-2015
New Life Nutritional SUPER FAT BURNER, bottle contains 30 CAPSULES, product is packaged in a white plastic bottle with black, red and green…
- FDA Drug
- Class I
- terminated
- Published 2014-12-31
On 2014-12-31 the FDA classified a Class I recall of New Life Nutritional SUPER FAT BURNER, bottle contains 30 CAPSULES, product is packaged in a white plastic bottle with black, red and green… by New Life Nutritional Center, citing marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed as Dietary Supplement….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0315-2015 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2014-03-25 |
| Published | 2014-12-31 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | New Life Nutritional Center |
| Distribution | LA, MA, NJ, NY, TX, VA |
Product
New Life Nutritional SUPER FAT BURNER, bottle contains 30 CAPSULES, product is packaged in a white plastic bottle with black, red and green font. Distributed by: New Life Nutritional under the following addresses: 714 West 181st Street New York, NY 10033, 153 East 188th Street Bronx, NY 10468, 316 Monroe Street Passaic, NJ 07055 and 200 Dyckman Street New York, NY 10040.
Reason
Marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed as Dietary Supplements due to the presence of undeclared and unapproved drugs.
Identifiers
| code_info | no identifying lot numbers present |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0315-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.